Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Can Segmental Growth Aid Cooper Companies' (COO) Q2 Earnings?

Published 05/24/2019, 07:54 AM
Updated 07/09/2023, 06:31 AM
XRAY
-
SYK
-
CNMD
-
COO
-

The Cooper Companies, Inc.’s (NYSE:COO) second-quarter fiscal 2019 results are scheduled to release on May 30, after market close.

The company expects to gain from segmental growth in the quarter to be reported.

Which Way Are Estimates Trending?

For the quarter to be reported, the Zacks Consensus Estimate for revenues is pegged at $653.37 million, suggesting year-over-year growth of 3.5%. The same for earnings is pegged at $2.76, indicating a year-over-year decline of 3.5%.

The Cooper Companies, Inc. Price and EPS Surprise

The Cooper Companies, Inc. price-eps-surprise | The Cooper Companies, Inc. Quote

Factors at Play

Cooper Companies reports revenues through two major segments — CooperVision (CVI) and CooperSurgical (CSI).

CVI’s Toric and Multifocal lenses, which make Cooper Companies a stalwart in the soft contact lenses market, are expected to drive second-quarter results. Additionally, CSI’s Surgical product portfolio is also expected to fuel growth.

Management at Cooper Companies expects to see higher contact lenses demand owing to the global transition to daily contact lenses by customers. Moreover, the company has made advancements in its customized product offerings which are expected to ramp up second-quarter sales.

It is encouraging to note that for fiscal 2019, Cooper Companies expects CVI sales within $1,968-$$1,995 million, higher than $1,940-$1,980 million anticipated earlier.

Coming to CSI, management is optimistic about the acquisitions of Blanchard and Incisive Surgical earlier this year. This is expected to boost the company’s specialty lens business in the quarter to be reported.

It is encouraging to note that for fiscal 2019, Cooper Companies expects CSI sales within $663-$681 million, up from the previous guidance of $660-$680 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

What Does Our Model Predict?

Our quantitative model indicates a positive earnings surprise for Cooper Companies. This is because a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to be able to beat estimates. However, this is not the case here.

Earnings ESP: The Earnings ESP for Cooper Companies is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Cooper Companies carries a Zacks Rank #3.

Stocks With Robust Q1 Results

Here are a few stocks that have reported solid results this earning season:

Stryker Corporation (NYSE:SYK) delivered first-quarter 2019 adjusted earnings per share of $1.88, beating the Zacks Consensus Estimate by 2.2%. Revenues of $3.52 billion were in line with the Zacks Consensus Estimate. The stock carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) reported adjusted earnings per share of 49 cents in the first quarter of 2019, beating the Zacks Consensus Estimate of 38 cents. Revenues of $946.2 million surpassed the Zacks Consensus Estimate of $917.1 million. The stock carries a Zacks Rank #2.

CONMED Corporation (NASDAQ:CNMD) reported first-quarter 2019 adjusted earnings per share of 57 cents, which beat the Zacks Consensus Estimate of 54 cents. Revenues were $218.4 million, surpassing the Zacks Consensus Estimate of $213 million. The stock carries a Zacks Rank of 2.

Looking for Stocks with Skyrocketing Upside?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Stryker Corporation (SYK): Free Stock Analysis Report

The Cooper Companies, Inc. (COO): Free Stock Analysis Report

DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

CONMED Corporation (CNMD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.